Skip to main content
Log in

Empirical bismuth-based quadruple therapy for H. pylori eradication: effective, less costly

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Chang YW, et al. Cost-Effectiveness of Empirical Bismuth-Based Quadruple Therapy and Tailored Therapy After Clarithromycin Resistance Tests for Helicobacter pylori Eradication. Digestive Diseases and Sciences : 23 Mar 2021. Available from: URL: http://doi.org/10.1007/s10620-021-06938-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Empirical bismuth-based quadruple therapy for H. pylori eradication: effective, less costly. PharmacoEcon Outcomes News 875, 9 (2021). https://doi.org/10.1007/s40274-021-7588-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7588-0

Navigation